This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Genetic factors

Authoring team

Genetic factors leading to congenital limb anomalies

The advent of genome-wide screening has facilitated the discovery of a variety of genes that may be implicated or causal in the development of congenital limb anomalies. Analysis of genes in more primitive organisms such as the fruit fly has facilitated the discovery of analogous pathways in human limb development.

The genetic defect can be classified according to the protein molecule that is deranged:

  • transcription factors:
    • Saethre-Chotzen Syndrome: TWIST gene located on chromosome 7p21
    • Holt-Oram Syndrome: TBX5 gene on chromosome 12q24.1
    • synpolydactyly: HOXD13 gene on choromosome 2q31-q32
    • Waardenburg's Syndrome type 1 and 3: PAX3 gene on chromosome 2q35
    • hand-foot-genital syndrome: HOXA13 gene on chromosome 7p15-p14.2
  • signaling protein:
    • Hunter-Thompson Syndrome: CDMP1 gene on chromosome 20q11.2
    • Aarskog Syndrome: FGD1 gene on chromosome Xp11.2
  • receptor proteins:
    • Apert's Syndrome: FGFR2 gene on chromosome 10q26
    • Pfeiffer's Syndrome: FGFR1 and FGFR2 genes on chromosomes 8p11.2-p11.1
    • Jackson-Weiss Syndrome: FGFR2 gene on chromosome 10q26
  • indeterminate:
    • Nager's Syndrome: chromosome allele 9q32

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.